These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 21715717)

  • 21. Association between bleeding, blood transfusion, and costs among patients with non-ST-segment elevation acute coronary syndromes.
    Rao SV; Kaul PR; Liao L; Armstrong PW; Ohman EM; Granger CB; Califf RM; Harrington RA; Eisenstein EL; Mark DB
    Am Heart J; 2008 Feb; 155(2):369-74. PubMed ID: 18215610
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antiplatelet intervention in acute coronary syndrome.
    Arora RR; Rai F
    Am J Ther; 2009; 16(5):e29-40. PubMed ID: 19092648
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antithrombotic therapy with fondaparinux in relation to interventional management strategy in patients with ST- and non-ST-segment elevation acute coronary syndromes: an individual patient-level combined analysis of the Fifth and Sixth Organization to Assess Strategies in Ischemic Syndromes (OASIS 5 and 6) randomized trials.
    Mehta SR; Boden WE; Eikelboom JW; Flather M; Steg PG; Avezum A; Afzal R; Piegas LS; Faxon DP; Widimsky P; Budaj A; Chrolavicius S; Rupprecht HJ; Jolly S; Granger CB; Fox KA; Bassand JP; Yusuf S;
    Circulation; 2008 Nov; 118(20):2038-46. PubMed ID: 18955665
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bleeding and transfusion in acute coronary syndromes: a shift in the paradigm.
    Bassand JP
    Heart; 2008 May; 94(5):661-6. PubMed ID: 18411361
    [No Abstract]   [Full Text] [Related]  

  • 25. [Complications related to procedures for acute coronary syndrome].
    Kawamura M; Daida H
    Nihon Rinsho; 2006 Apr; 64(4):788-93. PubMed ID: 16613199
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictors and impact of bleeding complications in percutaneous coronary intervention, acute coronary syndromes, and ST-segment elevation myocardial infarction.
    Manoukian SV
    Am J Cardiol; 2009 Sep; 104(5 Suppl):9C-15C. PubMed ID: 19695355
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discharge antithrombotic strategies among patients with acute coronary syndrome previously on warfarin anticoagulation: physician practice in the CRUSADE registry.
    Wang TY; Robinson LA; Ou FS; Roe MT; Ohman EM; Gibler WB; Smith SC; Peterson ED; Becker RC
    Am Heart J; 2008 Feb; 155(2):361-8. PubMed ID: 18215609
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The relationship between bleeding and adverse outcomes in ACS and PCI: pharmacologic and nonpharmacologic modification of risk.
    Manoukian SV
    J Invasive Cardiol; 2010 Mar; 22(3):132-41. PubMed ID: 20197582
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary intervention/ stenting.
    Lip GY; Huber K; Andreotti F; Arnesen H; Airaksinen KJ; Cuisset T; Kirchhof P; Marín F;
    Thromb Haemost; 2010 Jan; 103(1):13-28. PubMed ID: 20062939
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Editorial: do we need another bleeding definition? What does the Bleeding Academic Research Consortium definition have to offer?
    White HD
    Curr Opin Cardiol; 2011 Jul; 26(4):275-8. PubMed ID: 21499087
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drug insight: bleeding after percutaneous coronary intervention-risks, measures and impact of anticoagulant treatment options.
    Rothman MT
    Nat Clin Pract Cardiovasc Med; 2005 Sep; 2(9):465-74. PubMed ID: 16265587
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical review: gastrointestinal bleeding after percutaneous coronary intervention: a deadly combination.
    Foley P; Foley S; Kinnaird T; Anderson RA
    QJM; 2008 Jun; 101(6):425-33. PubMed ID: 18208848
    [TBL] [Abstract][Full Text] [Related]  

  • 33. API expert consensus document on management of ischemic heart disease.
    Association of Physicians of India
    J Assoc Physicians India; 2006 Jun; 54():469-80. PubMed ID: 16909697
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Temporal trend of in-hospital major bleeding among patients with non ST-elevation acute coronary syndromes.
    Elbarouni B; Elmanfud O; Yan RT; Fox KA; Kornder JM; Rose B; Spencer FA; Welsh RC; Wong GC; Goodman SG; Yan AT
    Am Heart J; 2010 Sep; 160(3):420-7. PubMed ID: 20826248
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Strategies to minimize bleeding complications of percutaneous coronary intervention.
    White HD
    Curr Opin Cardiol; 2009 Jul; 24(4):273-8. PubMed ID: 19474710
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Benefits and risks of clopidogrel use in patients with coronary artery disease: evidence from randomized studies and registries.
    Motovska Z; Kala P
    Clin Ther; 2008; 30 Pt 2():2191-202. PubMed ID: 19281914
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antiplatelet therapy: anti-ischemic benefits versus bleeding risk.
    Gibson CM
    J Interv Cardiol; 2008 Dec; 21 Suppl 1():S3-9. PubMed ID: 19090934
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pro: 'Antithrombotic therapy with warfarin, aspirin and clopidogrel is the recommended regime in anticoagulated patients who present with an acute coronary syndrome and/or undergo percutaneous coronary interventions'.
    Rubboli A; Halperin JL
    Thromb Haemost; 2008 Nov; 100(5):752-3. PubMed ID: 18989515
    [No Abstract]   [Full Text] [Related]  

  • 39. Risk factors for major bleeding and for minor bleeding after percutaneous coronary intervention in 634 consecutive patients with acute coronary syndromes.
    Pierre-Louis B; Aronow WS; Yoon JH; Ahn C; Kalapatapu K; Pucillo AL; Monsen CE
    Am J Ther; 2010; 17(4):e74-7. PubMed ID: 19455020
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Outcomes in elderly patients with acute coronary syndromes randomized to enoxaparin vs. unfractionated heparin: results from the SYNERGY trial.
    Lopes RD; Alexander KP; Marcucci G; White HD; Spinler S; Col J; Aylward PE; Califf RM; Mahaffey KW
    Eur Heart J; 2008 Aug; 29(15):1827-33. PubMed ID: 18519426
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.